Adjunctive intrauterine Foley’s Catheter Balloon adding to hypogastric artery ligation in the conservative management of morbid adherent placenta previa


  • Hany F. Sallam Department of Obstetrics and Gynecology, Aswan College of Medicine, Aswan, Egypt
  • Nahla W. Shady Department of Obstetrics and Gynecology, Aswan College of Medicine, Aswan, Egypt



Foley’s Catheter Balloon, Hypogastric artery ligation, Morbid adherent placenta previa


Background: Objective of present study was to demonstrate the efficacy of Foley’s catheters balloon tamponade as an adjuvant to control blood loss during and after a caesarian section in patient undergone hypogastric artery ligation (HAL) due to morbid adherent placenta previa (MAPP).

Methods: A single-center retrospective case-control clinical trial was carried out in a tertiary university hospital between March 2015 and March 2018, 124 women were undergoing cesarean delivery for MAPP, were managed conservatively either with HAL or HAL plus inflated Intrauterine Foley’s Catheter Balloon to control post-partum hemorrhage secondary to MAPP. In the case of conservative treatment protocol failure, cesarean hysterectomy was performed.

Results: 124 women were enrolled (n=62 in each group). group of women received HAL plus Intrauterine Foley’s Catheter Balloon (group II)) showed a significant reduction in intraoperative and 4 hours post-operative blood loss compared with (Group I) which received HAL without Intrauterine Foley’s Catheter Balloon. (P = 0.0001,0.0.015), so the overall estimated blood loss in group II showed significant reduction compared with group I (P = 0.0001).

Conclusions: Adjunctive intrauterine Foley's catheter balloon adding to HAL ligation in the management of MAPP is a novel combination approach have proved to be effective to control of intraoperative and PPH and to preserve the uterus as possible and change in the concept of MAPP management always mandates hysterectomy. And may become an alternative valid option to planned cesarean-hysterectomy in well-selected cases who have a strong desire for future fertility.


Grobman WA, Bailit JL, Rice MM et al. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol. 2014 Apr;123(4):804-10.

Pinas-Carrillo A, Chandraharan E. Management of morbidly adherent placenta. Obstet Gynaecol Reproduct Med. 2016 Oct 1;26(10):283-90.

Sentilhes L, Vayssière C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, Djoudi Ret al. Postpartum hemorrhage: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF) in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Biol Reprod. 2016;198:12-21.

Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013;92:1125-34.

Alchalabi HA, Lataifeh I, Obeidat B, Zayed F, Khader YS, Obeidat N. Morbidly adherent placenta previa in current practice: prediction and maternal morbidity in a series of 23 women who underwent hysterectomy. J Matern Fetal Neonatal Med. 2014;27(17):1734-7.

Royal College of Obstetricians and Gynaecologists (RCOG). Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management (Green-top Guideline No. 27). London: RCOG;2011:26.

Kayem G, Davy C, Goffinet F, Thomas C, Clement D, Cabrol D. Conservative versus extirpative Management in cases of placenta accreta. Obstet Gynecol. 2004;104:531-6.

Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526-34.

Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116:648-54.

Teixidor Vinas M, Belli AM, Arulkumaran S, Chandraharan E. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: A cohort study comparing outcomesbbefore and after introduction of the Triple-P procedure. Ultrasound Obstet Gynecol. 2015; 46:350-5.

Burchell RC. Physiology of internal iliac artery ligation. J Obstet Gynaec Brit Cwlth. 1968;75:642-51.

Bakri YN. Uterine tamponade-drain for hemorrhage secondary to placenta previa-accreta. Int J Gynecol Obstet. 1992;37(4):302-3.

Rauf M, Ebru C, Sevil E, Selim B. Conservative management of post‐partum hemorrhage secondary to placenta previa–accreta with hypogastric artery ligation and endo‐uterine hemostatic suture. J Obstet Gynaecol Res. 2017 Feb 1;43(2):265-71.

Shakur H, Roberts I, Bautista R, Collaborators C-T. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010;376:23-32.

Bailit JL, Grobman W, Rice MM, Reddy UM, Wapner RJ, Varner MW et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125:683-9.

Chandraharan E, Rao S, Belli AM, Arulkumaran S. The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117:191-4.

Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population‐based descriptive study. BJOG. 2014 Jan;121(1):62-71.

Maher MA, Abdelaziz A. Comparison between two management protocols for postpartum hemorrhage during cesarean section in placenta previa: balloon protocol versus non-balloon protocol. J Obstet Gynaecol Res. 2017;43(3):447-55.

Dabelea V, Schultze PM, McDuffie RS. Intrauterine balloon tamponade in the management of postpartum hemorrhage. Am J Perinatol. 2007;24(06):359-64.






Original Research Articles